MYC degradation via AURKB inhibition: a new brake in the path to T-ALL. | Blood Sci;2(2): 68-69, 2020 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

MYC degradation via AURKB inhibition: a new brake in the path to T-ALL.

Zhang, Wu; Pear, Warren S.

Affiliation

Zhang W; Department of Pathology and Laboratory Medicine, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Pear WS; Department of Pathology and Laboratory Medicine, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Blood Sci ; 2(2): 68-69, 2020 Apr.

Article in En | MEDLINE | ID: mdl-35402818

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Blood Sci Year: 2020 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Blood Sci Year: 2020 Document type: Article Affiliation country: United States Country of publication: United States